טוען...

Innovative approaches to clinical development and trial design

Pharmaceutical innovation is increasingly risky, costly and at times inefficient, which has led to a decline in industry productivity. Despite the increased investment in R&D by the industry, the number of new molecular entities achieving marketing authorization is not increasing. Novel approach...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: John J Orloff, Donald Stanski
פורמט: Artigo
שפה:Inglês
יצא לאור: Istituto Superiore di Sanità 2011-01-01
סדרה:Annali dell'Istituto Superiore di Sanità
נושאים:
גישה מקוונת:http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0021-25712011000100003&lng=en&tlng=en
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!